Ongoing patient enrollment in Phase 2b CHASE trial of KPI-012 in Persistent Corneal Epithelial Defect (PCED); topline results ...

For the quarter ended September 30, 2024, the Company had a loss from operations of $2.3 million, a 26% year-over-year improvement from $3.1 million for the comparable period of 2023, and a 9% ...

Herbal medicine is difficult to produce on an industrial scale. A team of Kobe University bioengineers manipulated the ...

Herbal medicinal products offer many beneficial health effects ... is better able to produce components for this class of ...

To better understand why some cancer patients struggle to fight off infections, Georgia Tech researchers have created tiny ...

Assistant Professor of Biomolecular Engineering Andy Yeh is designing completely artificial proteins that produce ...